SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-057944
Filing Date
2021-11-10
Accepted
2021-11-10 07:31:05
Documents
68
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0921_inmedpharma.htm   iXBRL 10-Q 540581
2 CERTIFICATION f10q0921ex31-1_inmedphar.htm EX-31.1 11353
3 CERTIFICATION f10q0921ex31-2_inmedphar.htm EX-31.2 11339
4 CERTIFICATION f10q0921ex32-1_inmedphar.htm EX-32.1 2960
5 CERTIFICATION f10q0921ex32-2_inmedphar.htm EX-32.2 2932
6 GRAPHIC img_001.jpg GRAPHIC 4089
7 GRAPHIC img_002.jpg GRAPHIC 4101
  Complete submission text file 0001213900-21-057944.txt   3168486

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE inm-20210930.xsd EX-101.SCH 49549
9 XBRL CALCULATION FILE inm-20210930_cal.xml EX-101.CAL 22047
10 XBRL DEFINITION FILE inm-20210930_def.xml EX-101.DEF 164851
11 XBRL LABEL FILE inm-20210930_lab.xml EX-101.LAB 335274
12 XBRL PRESENTATION FILE inm-20210930_pre.xml EX-101.PRE 174577
13 EXTRACTED XBRL INSTANCE DOCUMENT f10q0921_inmedpharma_htm.xml XML 280133
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39685 | Film No.: 211394409
SIC: 2834 Pharmaceutical Preparations